Prof. Dr. A.T. van Oosterom (EORTC President 2000-2003)
10 Nov 2021
The international oncology community has lost a true leader. Professor Allan T. van Oosterom studied in The Netherlands and graduated from the University of Leiden. He obtained his PhD in 1976, trained at the US National Cancer Institute and subsequently in 1978 became a Lecturer at the Royal Marsden Hospital in the United Kingdom. He returned to The Netherlands as a Senior Lecturer at the University of Leiden, and then moved to Antwerp in Belgium where he was Head of Oncology for 10 years and subsequently transferred to Leuven. Professor A.T, van Oosterom was always involved in clinical research and more specifically in the field of sarcomas, gynaecological and uro-genital tumours. In that respect, he had long association with the EORTC. He first became a member of the EORTC back in 1974 and took position on the Board of Directors in 1984, and was the EORTC President 2000-2003. In addition, he was a member of many organisations and was notably President of the Federation of European Cancer Societies (FECS). Professor A.T. van Oosterom inspired many doctors and scientists in carrying out forefront cancer clinical research, contributing through his own research agenda and through that of others to major therapeutic improvement for cancer patients.
It is with great sadness that we learn that Professor A.T. van Oosterom passed away. EORTC has lost a major peer who contributed to making oncology what it is today. His vision and dedication, relentlessly chasing the next oncological challenge to solve, collaborating across the world, inspired many oncologists worldwide.
We will remember Professor A.T. van Oosterom as a passionate and talented oncology leader.
Related News
Meet the new EORTC Board
9 Jul 2024
We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024
Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024
EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024